NDC Package 28877-7100-0 Certolizumab Pegol

Injection, Solution - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
28877-7100-0
Package Description:
4.81 g in 1 BOTTLE
Product Code:
Non-Proprietary Name:
Certolizumab Pegol
Substance Name:
Certolizumab Pegol
Usage Information:
This medication is used to reduce pain and swelling due to certain inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis). Some brands may also be used to treat a certain type of spine condition (axial spondyloarthritis) or a certain bowel condition (Crohn's disease). Certolizumab belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. It works by blocking TNF, a substance made by the body that causes inflammation.
11-Digit NDC Billing Format:
28877710000
Product Type:
Bulk Ingredient
Labeler Name:
Ucb Farchim Sa
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date:
06-28-2010
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 28877-7100-0?

The NDC Packaged Code 28877-7100-0 is assigned to an UNFINISHED drug package of 4.81 g in 1 bottle of Certolizumab Pegol, a bulk ingredient labeled by Ucb Farchim Sa. The product's dosage form is injection, solution and is administered via form.

Is NDC 28877-7100 included in the NDC Directory?

Yes, Certolizumab Pegol is an UNFINISHED PRODUCT with code 28877-7100 that is active and included in the NDC Directory. The product was first marketed by Ucb Farchim Sa on June 28, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 28877-7100-0?

The 11-digit format is 28877710000. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-128877-7100-05-4-228877-7100-00